21.68
前日終値:
$22.02
開ける:
$21.99
24時間の取引高:
116.39K
Relative Volume:
0.76
時価総額:
$281.19M
収益:
$56.54M
当期純損益:
$-30.70M
株価収益率:
-55.59
EPS:
-0.39
ネットキャッシュフロー:
$-31.05M
1週間 パフォーマンス:
-10.71%
1か月 パフォーマンス:
+2.65%
6か月 パフォーマンス:
+7.27%
1年 パフォーマンス:
+74.56%
Cidara Therapeutics Inc Stock (CDTX) Company Profile
名前
Cidara Therapeutics Inc
セクター
電話
858-752-6170
住所
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CDTX
Cidara Therapeutics Inc
|
21.68 | 314.91M | 56.54M | -30.70M | -31.05M | -0.39 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-12 | 開始されました | Citizens JMP | Mkt Outperform |
2025-01-27 | 再開されました | Cantor Fitzgerald | Overweight |
2024-12-13 | 開始されました | RBC Capital Mkts | Outperform |
2024-11-08 | 開始されました | Guggenheim | Buy |
2024-08-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
2021-12-03 | 再開されました | H.C. Wainwright | Buy |
2021-09-22 | アップグレード | WBB Securities | Buy → Strong Buy |
2021-03-04 | 開始されました | Aegis Capital | Buy |
2019-09-04 | アップグレード | Wedbush | Neutral → Outperform |
2018-07-26 | 開始されました | Citigroup | Buy |
2017-04-21 | 開始されました | Raymond James | Strong Buy |
2017-04-17 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-12 | 開始されました | Ladenburg Thalmann | Buy |
2017-04-11 | 再開されました | Wedbush | Outperform |
2017-02-22 | 繰り返されました | H.C. Wainwright | Buy |
2017-02-22 | アップグレード | WBB Securities | Sell → Hold |
2016-12-21 | 再開されました | Leerink Partners | Outperform |
2016-12-19 | 開始されました | H.C. Wainwright | Buy |
2016-09-23 | ダウングレード | WBB Securities | Hold → Sell |
2015-10-09 | アップグレード | WBB Securities | Sell → Hold |
2015-05-11 | 開始されました | Jefferies | Buy |
2015-05-11 | 開始されました | Leerink Partners | Outperform |
2015-05-11 | 開始されました | Needham | Buy |
2015-05-11 | 開始されました | Wedbush | Outperform |
2015-04-23 | 開始されました | WBB Securities | Sell |
すべてを表示
Cidara Therapeutics Inc (CDTX) 最新ニュース
Northern Trust Corp Has $913,000 Stock Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
Cidara Therapeutics Stock (CDTX): A Notable Contender in Antivirals - Value The Markets
Cidara Therapeutics (NASDAQ:CDTX) Given “Market Outperform” Rating at JMP Securities - Defense World
JMP Securities Reiterates Market Outperform Rating for Cidara Therapeutics (CDTX) | CDTX Stock News - GuruFocus
Cidara stock target holds at $47 by JMP on trial confidence - Investing.com Canada
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Analysts - Defense World
(CDTX) On The My Stocks Page - news.stocktradersdaily.com
Cidara Therapeutics: All Stars Aligning In Favor Of CD388 (NASDAQ:CDTX) - Seeking Alpha
Royal Bank of Canada Increases Cidara Therapeutics (NASDAQ:CDTX) Price Target to $35.00 - Defense World
Cidara Therapeutics’ (CDTX) Outperform Rating Reiterated at Royal Bank of Canada - Defense World
Cidara Therapeutics (NASDAQ:CDTX) Earns Buy Rating from Needham & Company LLC - Defense World
Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RB - GuruFocus
Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RBC Capital | CDTX Stock News - GuruFocus
RBC Capital Ups Price Target for Cidara Therapeutics (CDTX) Amid Optimism | CDTX Stock News - GuruFocus
Cidara Therapeutics (CDTX): Analyst Reiterates Buy Rating | CDTX Stock News - GuruFocus
RBC Raises Price Target on Cidara Therapeutics to $35 From $31, Keeps Outperform, Speculative Risk - marketscreener.com
Transcript : Cidara Therapeutics, Inc.Special Call - marketscreener.com
Seasonal Influenza Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cidara, Moderna, SAB Therapeutics, Sinovac Biotech, Novartis - Barchart.com
Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
CDTX Stock Price and Chart — NASDAQ:CDTX - TradingView
When (CDTX) Moves Investors should Listen - news.stocktradersdaily.com
Cidara Therapeutics (CDTX) Target Price Raised by Guggenheim | CDTX Stock News - GuruFocus
Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenh - GuruFocus
Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenheim | CDTX Stock News - GuruFocus
Cidara Therapeutics price target raised to $50 from $35 at Guggenheim - TipRanks
Cidara Therapeutics to Host Virtual R&D Day to Discuss - GlobeNewswire
Revolutionary Once-Per-Year Universal Flu Prevention: Cidara Unveils Phase 2b Trial Updates at R&D Day - Stock Titan
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call - MSN
Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00 - Defense World
Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, JMP Securities Analyst Says - Defense World
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q1 2025 Earnings Call Transcript - Insider Monkey
Guggenheim Raises Price Target for Cidara Therapeutics (CDTX) to $35.00 | CDTX Stock News - GuruFocus
Analysts Offer Insights on Healthcare Companies: Aveanna Healthcare Holdings (AVAH), Caribou Biosciences (CRBU) and Cidara Therapeutics (CDTX) - The Globe and Mail
StockNews.com Upgrades Cidara Therapeutics (NASDAQ:CDTX) to Sell - Defense World
Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities - GuruFocus
Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities | CDTX Stock News - GuruFocus
RBC Cuts Price Target on Cidara Therapeutics to $31 From $34, Keeps Outperform, Speculative Risk - marketscreener.com
Cidara Therapeutics (CDTX) Target Price Raised to $35 by Guggenheim | CDTX Stock News - GuruFocus
Cidara Therapeutics (CDTX) Sees Price Target Increase by Citizens JMP | CDTX Stock News - GuruFocus
Cidara Therapeutics: Q1 Earnings Snapshot - New Haven Register
Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... - Yahoo Finance
Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in Influenza Prevention Amid Financial Challenges - GuruFocus
Cidara Therapeutics Reports Q1 2025 Financial Results - TipRanks
CDTX Targets Key Data Release for Influenza Treatment by Mid-202 - GuruFocus
Cidara Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CDTX Targets Key Data Release for Influenza Treatment by Mid-2025 | CDTX Stock News - GuruFocus
Cidara Therapeutics reports Q1 EPS ($1.66) vs. ($2.28) last year - TipRanks
Cidara Therapeutics Inc (CDTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):